• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PFIZER MANUFACTURING BELGIUM NV GENOTROPIN PEN DEVICE 12 MG; INJECTOR, PEN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PFIZER MANUFACTURING BELGIUM NV GENOTROPIN PEN DEVICE 12 MG; INJECTOR, PEN Back to Search Results
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/01/2023
Type of Reportable Event Malfunction
Event or Problem Description
My son used norditropin for growth hormone deficiency.There is currently a national shortage of this drug so we were told to go with genotropin.I have contacted pfizer numerous times (3.5 to 4 hour hold time) to get the prescription.The genotropin will be delivered today however there is also a national shortage for the pen device which is needed to administer the drug.In the process of getting the drug, pfizer did not tell me i also needed a prescription for the pen device, so i am starting the whole process over with my son's doctor.In contacting pfizer they have no idea when a pen device will be available which will result in my son not being able to get his medication.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GENOTROPIN PEN DEVICE 12 MG
Common Device Name
INJECTOR, PEN
Manufacturer (Section D)
PFIZER MANUFACTURING BELGIUM NV
genotropin pen device 12 mg
MDR Report Key16502113
Report NumberMW5115509
Device Sequence Number14024126
Product Code NSC
Combination Product (Y/N)N
Initial Reporter StateAZ
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Voluntary
Initial Reporter Occupation Patient
Type of Report Initial
Report Date (Section B) 03/01/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date03/06/2023
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
GENOTROPIN
Outcome Attributed to Adverse Event Other;
Patient Age13 YR
Patient SexMale
Patient Weight36 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-